Skip to main content
Erschienen in: Supportive Care in Cancer 8/2003

01.08.2003 | Original Article

Factors predicting fatigue in breast cancer patients

verfasst von: Shahpar Haghighat, Mohammad Esmail Akbari, Kourosh Holakouei, Abbas Rahimi, Ali Montazeri

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2003

Einloggen, um Zugang zu erhalten

Abstract

A prospective study was designed to investigate the factors predicting fatigue in breast cancer patients using the Cancer Fatigue Scale (CFS) in addition to the Hospital Anxiety and Depression Scale (HADS) and a questionnaire containing items on demographic and clinical data, and measures of patients' physical symptoms. The CFS measures total fatigue score ranging from 0 (lowest level) to 60 (highest level) and contains three subscales namely: physical, affective and cognitive fatigue. The questionnaires were administered to a consecutive sample of breast cancer patients attending the Iranian Center for Breast Cancer either for their treatment or follow-up examination. In all, 112 patients were studied. The mean age of the respondents was 45.7 years (SD11.0). Most had stage II breast cancer (67%) and had completed their initial treatment (45%). The mean total fatigue score of the patients was 18.7 (SD 13.5) and overall 49% reported experiencing fatigue to some degree (from quite a bit to very much). Severe anxiety and depression was reported by 16% and 32%, respectively. The regression analysis revealed that fatigue was predicted by depression (P=0.003), pain (P=0.005), current tamoxifen use (P=0.001), undergoing mastectomy (P=0.03) and anxiety (P=0.04). The other variables studied did not emerge as significant predictors of fatigue in the regression analysis. The study findings suggest that in comparison to treatment factors, physical and psychological symptoms have a more important role in cancer-related fatigue and that fatigue should be recognized and managed even before commencing breast cancer treatment.
Literatur
1.
Zurück zum Zitat Andrykowski MA, Curran SL, Lightner R (1998) Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med 21:1–18CrossRefPubMed Andrykowski MA, Curran SL, Lightner R (1998) Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med 21:1–18CrossRefPubMed
2.
Zurück zum Zitat Atkinson A, Barsevick A, Cella D, et al (2000) NCCN practice guidelines for cancer-related fatigue. Oncol New York 14 [Suppl 10]:151–161 Atkinson A, Barsevick A, Cella D, et al (2000) NCCN practice guidelines for cancer-related fatigue. Oncol New York 14 [Suppl 10]:151–161
3.
Zurück zum Zitat Berger AM, Farr L (1999) The influence of daytime inactivity and nighttime restlessness on cancer related fatigue. Oncol Nurs Forum 26:1663–1671PubMed Berger AM, Farr L (1999) The influence of daytime inactivity and nighttime restlessness on cancer related fatigue. Oncol Nurs Forum 26:1663–1671PubMed
4.
Zurück zum Zitat Bower JE, Ganz PA, Desmond KA. Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743–753PubMed Bower JE, Ganz PA, Desmond KA. Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743–753PubMed
5.
Zurück zum Zitat Broeckel JA, Jacobson PB, Horton J, Balducci L, Lymman GH (1998) Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16:1689–1696PubMed Broeckel JA, Jacobson PB, Horton J, Balducci L, Lymman GH (1998) Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16:1689–1696PubMed
6.
Zurück zum Zitat Cella D (1997) Manual of the functional assessment of chronic illness therapy (FACIT) scales, vol 4. Evanston Northwestern Healthcare, Chicago Cella D (1997) Manual of the functional assessment of chronic illness therapy (FACIT) scales, vol 4. Evanston Northwestern Healthcare, Chicago
7.
Zurück zum Zitat Chan CWH, Molassiotis A (2000) The impact of fatigue on Chinese cancer patients in Hong Kong. Support Care Cancer 9:18–24CrossRef Chan CWH, Molassiotis A (2000) The impact of fatigue on Chinese cancer patients in Hong Kong. Support Care Cancer 9:18–24CrossRef
9.
Zurück zum Zitat Curt GA, Breitbart W, Cella D, et al (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360PubMed Curt GA, Breitbart W, Cella D, et al (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360PubMed
10.
Zurück zum Zitat de Jong N, Courtens AM, Abu-Saad HH, Schouten HC (2002) Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nurs 25:283–297PubMed de Jong N, Courtens AM, Abu-Saad HH, Schouten HC (2002) Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nurs 25:283–297PubMed
11.
Zurück zum Zitat Fürst CJ, Ahsberg E (2001) Dimensions of fatigue during radiotherapy. An application of Multidimensional Fatigue Inventory. Support Care Cancer 9:355–360PubMed Fürst CJ, Ahsberg E (2001) Dimensions of fatigue during radiotherapy. An application of Multidimensional Fatigue Inventory. Support Care Cancer 9:355–360PubMed
12.
Zurück zum Zitat Glaus A (1993) Assessment of fatigue in cancer and non-cancer patients and in healthy individuals. Support Care Cancer 1:305–315PubMed Glaus A (1993) Assessment of fatigue in cancer and non-cancer patients and in healthy individuals. Support Care Cancer 1:305–315PubMed
13.
Zurück zum Zitat Glaus A (2001) Fatigue in patients with cancer—from orphan topic to global concern. Support Care Cancer 9:1–3CrossRefPubMed Glaus A (2001) Fatigue in patients with cancer—from orphan topic to global concern. Support Care Cancer 9:1–3CrossRefPubMed
14.
Zurück zum Zitat Hann DM, Denniston MM, Baker F (2000) Measurement of fatigue in cancer patients: further validation of the Fatigue Symptom Inventory. Qual Life Res 9:847–854CrossRefPubMed Hann DM, Denniston MM, Baker F (2000) Measurement of fatigue in cancer patients: further validation of the Fatigue Symptom Inventory. Qual Life Res 9:847–854CrossRefPubMed
15.
Zurück zum Zitat Hayes JR (1991) Depression and chronic fatigue in cancer patients. Prim Care 18:327–339PubMed Hayes JR (1991) Depression and chronic fatigue in cancer patients. Prim Care 18:327–339PubMed
16.
Zurück zum Zitat Herrmann C (1997) International experience with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 42:17–41CrossRefPubMed Herrmann C (1997) International experience with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 42:17–41CrossRefPubMed
17.
Zurück zum Zitat Irvine DM, Vincent L, Graydon JE, Bubela N (1998) Fatigue in women with breast cancer receiving radiation therapy. Cancer Nurs 21:127–135PubMed Irvine DM, Vincent L, Graydon JE, Bubela N (1998) Fatigue in women with breast cancer receiving radiation therapy. Cancer Nurs 21:127–135PubMed
18.
Zurück zum Zitat Jacobson PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GHC (1999) Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage 18:233–242CrossRefPubMed Jacobson PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GHC (1999) Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage 18:233–242CrossRefPubMed
19.
Zurück zum Zitat Lavidor M, Weller A, Babkoff H (2003) How sleep is related to fatigue. Br J Health Psychol 8:95–105CrossRefPubMed Lavidor M, Weller A, Babkoff H (2003) How sleep is related to fatigue. Br J Health Psychol 8:95–105CrossRefPubMed
20.
Zurück zum Zitat Magnusson K, Moller A, Ekman T, Wallgren A (1999) A qualitative study to explore the experience of fatigue in cancer patients. Eur J Cancer Care 8:224–232CrossRef Magnusson K, Moller A, Ekman T, Wallgren A (1999) A qualitative study to explore the experience of fatigue in cancer patients. Eur J Cancer Care 8:224–232CrossRef
21.
Zurück zum Zitat Mast ME (1998) Correlates of fatigue in survivors of breast cancer. Cancer Nurs 21:136–142PubMed Mast ME (1998) Correlates of fatigue in survivors of breast cancer. Cancer Nurs 21:136–142PubMed
22.
Zurück zum Zitat Mendoza TR, Wang XS, Cleeland CS, et al (1999) The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85:1186–1196PubMed Mendoza TR, Wang XS, Cleeland CS, et al (1999) The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85:1186–1196PubMed
23.
Zurück zum Zitat Molassiotis A, Chan CWH (2001) Fatigue patterns in Chinese patients receiving chemotherapy. Eur J Oncol Nurs 5:60–70CrossRef Molassiotis A, Chan CWH (2001) Fatigue patterns in Chinese patients receiving chemotherapy. Eur J Oncol Nurs 5:60–70CrossRef
24.
Zurück zum Zitat Montazeri A, Harirchi I, Vahdani M, et al (2000) Anxiety and depression in Iranian breast cancer patients before and after diagnosis. Eur J Cancer Care 9:151–157CrossRef Montazeri A, Harirchi I, Vahdani M, et al (2000) Anxiety and depression in Iranian breast cancer patients before and after diagnosis. Eur J Cancer Care 9:151–157CrossRef
25.
Zurück zum Zitat Norusis MJ (1999) SPSS regression models 10.0. SPSS, Chicago, IL Norusis MJ (1999) SPSS regression models 10.0. SPSS, Chicago, IL
26.
Zurück zum Zitat Okuyama T, Akechi T, Kugaya A, et al (2000) Development and validation of the cancer fatigue scale: a brief three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage 19:5–14CrossRefPubMed Okuyama T, Akechi T, Kugaya A, et al (2000) Development and validation of the cancer fatigue scale: a brief three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage 19:5–14CrossRefPubMed
27.
Zurück zum Zitat Okuyama T, Akechi T, Kugaya A, et al (2000) Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale. Support Care Cancer 8:215–222CrossRefPubMed Okuyama T, Akechi T, Kugaya A, et al (2000) Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale. Support Care Cancer 8:215–222CrossRefPubMed
28.
Zurück zum Zitat Payne DK, Hoffman RG, Theodoulou M, et al (1999) Screening for anxiety and depression in women with breast cancer. Psychiatry and medical oncology gear up for managed care. Psychosomatics 40:64–69PubMed Payne DK, Hoffman RG, Theodoulou M, et al (1999) Screening for anxiety and depression in women with breast cancer. Psychiatry and medical oncology gear up for managed care. Psychosomatics 40:64–69PubMed
29.
Zurück zum Zitat Piper BF, Dibble SL, Dodd MJ (1998) The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25:677–684PubMed Piper BF, Dibble SL, Dodd MJ (1998) The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25:677–684PubMed
30.
Zurück zum Zitat Portenoy RK, Itri LM (1999) Cancer-related fatigue: guidelines for evaluation and management. Oncologist 4:1–10PubMed Portenoy RK, Itri LM (1999) Cancer-related fatigue: guidelines for evaluation and management. Oncologist 4:1–10PubMed
31.
Zurück zum Zitat Schwartz AL (1998) The Schwartz Cancer Fatigue Scale: testing reliability and validity. Oncol Nurs Forum 25:711–717PubMed Schwartz AL (1998) The Schwartz Cancer Fatigue Scale: testing reliability and validity. Oncol Nurs Forum 25:711–717PubMed
32.
Zurück zum Zitat Servaes P, van der Werf S, Prins J, Verhagen S, Bleijenberg G (2001) Fatigue in disease-free cancer patients compared with fatigue in patients with chronic fatigue syndrome. Support Care Cancer 9:11–17CrossRefPubMed Servaes P, van der Werf S, Prins J, Verhagen S, Bleijenberg G (2001) Fatigue in disease-free cancer patients compared with fatigue in patients with chronic fatigue syndrome. Support Care Cancer 9:11–17CrossRefPubMed
33.
Zurück zum Zitat Servaes P, Verhagen C, Bleijenberg G (2002) Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 38:27–43PubMed Servaes P, Verhagen C, Bleijenberg G (2002) Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 38:27–43PubMed
34.
35.
Zurück zum Zitat Stone P, Richards M, A'Hern R, Hardy J (2000) A study to investigate the prevalence, severity and correlates of fatigue among patients with a control group of volunteers without cancer. Ann Oncol 11:561–567PubMed Stone P, Richards M, A'Hern R, Hardy J (2000) A study to investigate the prevalence, severity and correlates of fatigue among patients with a control group of volunteers without cancer. Ann Oncol 11:561–567PubMed
36.
Zurück zum Zitat Visser RM, Smets MA (1998) Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer 6:101–108 Visser RM, Smets MA (1998) Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer 6:101–108
37.
Zurück zum Zitat Winningham ML, Nail LM, Burke MB, et al (1994) Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum 12:23–36 Winningham ML, Nail LM, Burke MB, et al (1994) Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum 12:23–36
38.
Zurück zum Zitat Woo B, Dibble SL, Piper BF, Keating SB, Weiss MC (1998) Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum 25:915–920PubMed Woo B, Dibble SL, Piper BF, Keating SB, Weiss MC (1998) Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum 25:915–920PubMed
39.
Zurück zum Zitat Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression scale. Acta Psychiatr Scand 67:361–370PubMed Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression scale. Acta Psychiatr Scand 67:361–370PubMed
40.
Zurück zum Zitat Zorn M, Rowland JH, Varricchio CG (2002) Symptom management in cancer: pain, depression, and fatigue. Current bibliographies in medicine, no. 2002-4. National Library of Medicine, Bethesda (http://www.nlm.nih.gov/pubs/cbm/cancersymptoms.pdf) Zorn M, Rowland JH, Varricchio CG (2002) Symptom management in cancer: pain, depression, and fatigue. Current bibliographies in medicine, no. 2002-4. National Library of Medicine, Bethesda (http://​www.​nlm.​nih.​gov/​pubs/​cbm/​cancersymptoms.​pdf)
Metadaten
Titel
Factors predicting fatigue in breast cancer patients
verfasst von
Shahpar Haghighat
Mohammad Esmail Akbari
Kourosh Holakouei
Abbas Rahimi
Ali Montazeri
Publikationsdatum
01.08.2003
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2003
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-003-0473-5

Weitere Artikel der Ausgabe 8/2003

Supportive Care in Cancer 8/2003 Zur Ausgabe

Society News

August 2003

Forthcoming Meetings

August 2003

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.